Ledger.Open graph →
SEC Form D · filed July 14, 2015

Afferent Pharmaceuticals, Inc

Offering
$55.0M
Sold
$55.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Mateo, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Kevin S. Starr · San Mateo, CADirectorMichael S. Kitt · San Mateo, CAExecArthur S. Pappas · San Mateo, CADirectorAnthony S. Ford · San Mateo, CAExecPeter S. Hirth · San Mateo, CADirectorLiam S. Ratcliffe · San Mateo, CADirectorJesse S. Treu · San Mateo, CADirectorKathleen S. Glaub · San Mateo, CAExec · DirectorKevin S. Starr · San Mateo, CADirectorMichael S. Kitt · San Mateo, CAExecArthur S. Pappas · San Mateo, CADirectorAnthony S. Ford · San Mateo, CAExecKathleen S. Glaub · San Mateo, CAExec · DirectorPeter S. Hirth · San Mateo, CADirectorLiam S. Ratcliffe · San Mateo, CADirectorJesse S. Treu · San Mateo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗